Skip to main content
. Author manuscript; available in PMC: 2022 Mar 28.
Published in final edited form as: J Pediatr. 2020 Sep 23;229:294–298.e3. doi: 10.1016/j.jpeds.2020.09.056

Table 3.

Adverse Events Outcomes Within Randomized Infants (online only)

Group C (n=55)

Received Antibiotics Did not receive Antibiotics p-value††

(n) 41 (74.6) 14 (25.5)
Necrotizing enterocolitis 3 (7.3) -- 0.3
Late Onset Sepsis 7(17.1) 2 (14.3) 0.8
Bronchopulmonary dysplasia 9 (22.0) 2 (14.3) 0.53
Death 8 (19.5) 1 (7.1) 0.28
Adverse events outcome composite 19 (46.3) 4 (28.6) 0.24

Infants in group C receiving antibiotics in the first postnatal 48 hours regardless of assigned treatment group Presented as n(%)

††

Chi-Square Test.